Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Significant Decrease in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the target of a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 751 shares, a drop of 84.8% from the June 15th total of 4,938 shares. Based on an average daily volume of 13,699 shares, the short-interest ratio is currently 0.1 days.

Fortress Biotech Price Performance

NASDAQ:FBIOP traded up $0.14 on Monday, hitting $18.70. The company’s stock had a trading volume of 10,525 shares, compared to its average volume of 23,764. Fortress Biotech has a one year low of $6.27 and a one year high of $21.43. The stock has a fifty day moving average of $18.46 and a two-hundred day moving average of $14.61.

About Fortress Biotech

(Get Free Report)

Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.

The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.

See Also

• Five stocks we like better than Fortress Biotech
• The SK Hynix IPO and 2027’s AI Memory Squeeze
• Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
• Why Welltower’s Growth Story Might Outrun Its Rich Valuation
• One Short- and One Long-Term ETF for Quantum Computing Bulls